• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

PTC Reports Positive Phase II Huntington’s Data, FDA Lifts Partial Clinical Hold

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jun 20, 2024 at 06:02: PM
via PTC Therapeutics announced Thursday that its Huntington’s disease candidate PTC518 is no longer subject to an FDA partial clinical hold after it showed positive interim results from a Phase II study.

article source
 

<



Similar threads

cafead
3rd time&#039;s the charm? PTC will get another chance to keep Translarna&#039;s European...
Replies
0
Views
74
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
PTC&#039;s re-examination bid for DMD drug Translarna falls short in Europe
Replies
0
Views
100
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
PTC&#039;s plans crash into regulatory reality as FDA demands data on 2 candidates,...
Replies
0
Views
85
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
PTC to sell spinal muscular atrophy drug royalties for $1B
Replies
0
Views
67
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
Replies
0
Views
65
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote